Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $6,066 | 13 | 34.4% |
| Food and Beverage | $4,311 | 77 | 24.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,500 | 1 | 14.2% |
| Consulting Fee | $2,400 | 1 | 13.6% |
| Honoraria | $2,000 | 1 | 11.4% |
| Education | $328.44 | 4 | 1.9% |
| Gift | $8.74 | 1 | 0.0% |
| Unspecified | $0 | 9 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UroGPO LLC | $6,418 | 13 | $0 (2020) |
| INTUITIVE SURGICAL, INC. | $4,349 | 18 | $0 (2024) |
| NeoTract Inc. | $2,872 | 8 | $0 (2018) |
| Avadel Specialty Pharmaceuticals, LLC | $2,565 | 3 | $0 (2018) |
| Janssen Biotech, Inc. | $587.37 | 38 | $0 (2019) |
| Astellas Pharma US Inc | $236.17 | 4 | $0 (2023) |
| Medtronic USA, Inc. | $136.25 | 1 | $0 (2018) |
| Ferring Pharmaceuticals Inc. | $129.64 | 1 | $0 (2019) |
| Endo Pharmaceuticals Inc. | $112.23 | 4 | $0 (2019) |
| Amgen Inc. | $97.77 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $587.21 | 9 | INTUITIVE SURGICAL, INC. ($568.23) |
| 2023 | $158.70 | 4 | Astellas Pharma US Inc ($94.99) |
| 2022 | $99.99 | 2 | Astellas Pharma US Inc ($99.99) |
| 2021 | $0 | 1 | SN Holdings, LLC |
| 2020 | $3.82 | 2 | Travere Therapeutics, Inc. ($3.82) |
| 2019 | $6,087 | 23 | Intuitive Surgical, Inc. ($3,780) |
| 2018 | $10,224 | 41 | UroGPO LLC ($4,359) |
| 2017 | $454.56 | 25 | Janssen Biotech, Inc. ($252.03) |
All Payment Transactions
107 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/06/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Oncology | ||||||
| 05/21/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $32.71 | General |
| Category: SURGERY | ||||||
| 05/14/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $43.56 | General |
| Category: SURGERY | ||||||
| 04/09/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $344.29 | General |
| Category: SURGERY | ||||||
| 04/09/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $97.50 | General |
| Category: SURGERY | ||||||
| 04/09/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Gift | In-kind items and services | $8.74 | General |
| Category: SURGERY | ||||||
| 02/27/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $41.43 | General |
| Category: SURGERY | ||||||
| 2024 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 2024 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 12/05/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $94.99 | General |
| 11/08/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $32.02 | General |
| Category: Oncology | ||||||
| 02/07/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $31.69 | General |
| Category: Urology | ||||||
| 2023 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 11/04/2022 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 2022 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 2021 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 04/15/2020 | Travere Therapeutics, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $3.82 | General |
| Category: Kidney Stones | ||||||
| 2020 | UroGPO LLC | — | — | — | $0.00 | Ownership |
| 11/20/2019 | Amgen Inc. | XGEVA (Biological) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Oncology | ||||||
| 07/20/2019 | Sun Pharmaceutical Industries Inc. | YONSA (Drug) | Food and Beverage | Cash or cash equivalent | $13.98 | General |
| Category: Oncology | ||||||
| 07/10/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: Oncology | ||||||
| 06/18/2019 | UroGPO LLC | — | Food and Beverage | Cash or cash equivalent | $15.24 | General |
| 06/10/2019 | Ferring Pharmaceuticals Inc. | NOCDURNA (Drug) | Education | In-kind items and services | $129.64 | General |
| Category: UROLOGY | ||||||
| 05/31/2019 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), AVEED, EDEX | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: UROLOGY | ||||||
| 05/29/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 814 | 2,034 | $286,015 | $49,023 |
| 2022 | 17 | 696 | 2,536 | $260,818 | $42,701 |
| 2021 | 18 | 744 | 2,323 | $297,158 | $49,898 |
| 2020 | 15 | 709 | 2,412 | $272,435 | $43,431 |
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 149 | 204 | $77,520 | $17,851 | 23.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 162 | 189 | $51,030 | $11,753 | 23.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 94 | 114 | $78,782 | $6,303 | 8.0% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 70 | 106 | $27,449 | $5,463 | 19.9% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 16 | 21 | $24,992 | $2,694 | 10.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $12,068 | $2,246 | 18.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 77 | 95 | $5,795 | $688.80 | 11.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 121 | 163 | $2,445 | $552.42 | 22.6% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 13 | 19 | $1,393 | $360.24 | 25.9% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 14 | 17 | $1,087 | $222.90 | 20.5% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 22 | 27 | $783.00 | $213.57 | 27.3% |
| 87088 | Bacterial urine culture | Office | 2023 | 15 | 24 | $672.00 | $190.32 | 28.3% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2023 | 13 | 22 | $528.00 | $186.56 | 35.3% |
| 87077 | Bacterial culture for aerobic isolates | Office | 2023 | 14 | 23 | $483.00 | $182.16 | 37.7% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 12 | 988 | $988.00 | $115.99 | 11.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 173 | 219 | $56,910 | $12,846 | 22.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 81 | 95 | $34,775 | $7,325 | 21.1% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2022 | 63 | 110 | $25,690 | $5,456 | 21.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 69 | 79 | $52,693 | $4,226 | 8.0% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2022 | 12 | 12 | $16,524 | $3,544 | 21.4% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2022 | 17 | 23 | $25,985 | $2,156 | 8.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $10,146 | $1,813 | 17.9% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Facility | 2022 | 14 | 14 | $11,088 | $1,592 | 14.4% |
| 55700 | Biopsy of prostate gland | Facility | 2022 | 21 | 21 | $14,931 | $1,487 | 10.0% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2022 | 20 | 25 | $1,475 | $479.03 | 32.5% |
About Dr. David Dimarco, MD
Dr. David Dimarco, MD is a Urology healthcare provider based in Springfield, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174540751.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Dimarco, MD has received a total of $17,615 in payments from pharmaceutical and medical device companies, with $587.21 received in 2024. These payments were reported across 107 transactions from 17 companies. The most common payment nature is "Travel and Lodging" ($6,066).
As a Medicare-enrolled provider, Dimarco has provided services to 2,963 Medicare beneficiaries, totaling 9,305 services with total Medicare billing of $185,054. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Springfield, OR
- Active Since 07/17/2006
- Last Updated 09/28/2022
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1174540751
Products in Payments
- Da Vinci Surgical System (Device) $4,349
- UROLIFT (Device) $2,633
- Noctiva (Drug) $2,565
- Erleada (Drug) $306.01
- ZYTIGA (Drug) $281.36
- INTERSTIM (Device) $136.25
- UroLift (Device) $133.99
- NOCDURNA (Drug) $129.64
- Urolift - UL400 (Device) $105.26
- Prolia (Biological) $76.03
- AVEED (Biological) $65.00
- XIAFLEX (Biological) $47.23
- Myrbetriq (Drug) $41.19
- LYNPARZA (Drug) $32.02
- GEMTESA (Drug) $31.69
- XGEVA (Biological) $21.74
- PLUVICTO (Drug) $18.98
- YONSA (Drug) $13.98
- OFIRMEV (Drug) $11.72
- (815) Thiola (Drug) $3.82
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Springfield
Bryan Mehlhaff, Md, MD
Urology — Payments: $1.5M
Kevin Mcvary, Md, MD
Urology — Payments: $405,504
Bradley Schwartz, M.d, M.D
Urology — Payments: $105,537
Robert Nadler, Md, MD
Urology — Payments: $93,691
Kevin Krughoff
Urology — Payments: $54,104
Dr. Eric Espinosa
Urology — Payments: $23,023